Venclexta(venetoclax) inhibits a certain protein in cancer cells (abnormal lymphocytesproduced in chronic lymphocytic leukemia) that helps keep those cells alive andmakes them resistant to chemotherapy. Venetoclax binds to this protein, whichhelps kill the cancerous lymphocytes in blood and bone marrow.
Venclexta is used to treat chronic lymphocytic leukemia (CLL)in adults with 17p deletion. Venclexta is used only if you have a specific genetic marker, for which your doctor will test.
Delivery Time: 10 Days